MGMT and central nervous system cancer: Significantly, the hypermethylation of the MGMT promoter and low MGMT expression may play a crucial role in glioma occurrence and progression and were found to be responsible for the favorable prognosis of LGGs and GBMs treated with TMZ with or without additional radiotherapy [19,20].